Stock 3KY HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Hansoh Pharmaceutical Group Company Limited Börse Stuttgart

Equities

3KY

KYG549581067

Pharmaceuticals

Real-time Estimate Tradegate
Other stock markets
 09:22:44 27/06/2024 BST 		5-day change 1st Jan Change
1.965 EUR -0.76% Intraday chart for Hansoh Pharmaceutical Group Company Limited -2.94% +15.79%
06-14 Hansoh Pharmaceutical Slashes Conversion Price of Convertible Bonds MT
04-29 Hansoh Pharmaceutical Group Company Limited Announces Executive Changes, Effective April 29, 2024 CI

Business Summary

Hansoh Pharmaceutical Group Company Limited specializes in the development, manufacture and marketing of pharmaceutical products for the treatment of tumor, infectious, metabolic and autoimmune diseases. Net sales break down by revenue source as follows:

- sales of pharmaceutical products (99.1%);

- sales of research and development services (0.9%).

Sales per Business

HKD in Million2022Weight2023Weight Delta
Oncology
61.1 %
6,421 58.9 % 6,817 61.1 % +6.16%
Central Nervous System Diseases
13.5 %
1,737 15.9 % 1,511 13.5 % -13.05%
Metabolic Diseases and Others
12.9 %
1,299 11.9 % 1,435 12.9 % +10.51%
Anti-infective Diseases
12.6 %
1,452 13.3 % 1,402 12.6 % -3.46%

Sales per region

HKD in Million2022Weight2023Weight Delta
China
100.0 %
10,911 100.0 % 11,165 100.0 % +2.33%

Managers

Managers TitleAgeSince
Hui Juan Zhong CEO
 Chief Executive Officer 63 01/12/15
Sheng Li Zhong SEC
 Corporate Secretary 56 -

Members of the board

Members of the board TitleAgeSince
Guo Qiang Lin BRD
 Director/Board Member 81 30/05/19
Sheung Wai Chan BRD
 Director/Board Member 70 13/06/19
Dong Tao Yang BRD
 Director/Board Member 67 -
Hui Juan Zhong CEO
 Chief Executive Officer 63 01/12/15
Ai Feng Lyu BRD
 Director/Board Member 47 10/03/16
Yu An Sun BRD
 Director/Board Member 38 01/12/15

Shareholders

NameEquities%Valuation
Yu An Sun
65.71 %
3,900,408,100 65.71 % 8 007 M €
Jun Da Cen
16.00 %
950,000,000 16.00 % 1 950 M €
UBS Asset Management (Hong Kong) Ltd.
0.4597 %
27,285,481 0.4597 % 56 M €
Fidelity Management & Research (Hong Kong) Ltd.
0.4494 %
26,674,000 0.4494 % 55 M €
GF Fund Management Co., Ltd.
0.2904 %
17,240,000 0.2904 % 35 M €
Bank of Communications Schroder Fund Management Co., Ltd.
0.1787 %
10,606,000 0.1787 % 22 M €
Bosera Asset Management Co., Ltd.
0.1720 %
10,210,000 0.1720 % 21 M €
HuaAn Fund Management Co., Ltd.
0.1713 %
10,170,000 0.1713 % 21 M €
China Asset Management Co., Ltd.
0.1465 %
8,694,000 0.1465 % 18 M €
Fullgoal Fund Management Co., Ltd.
0.0826 %
4,902,475 0.0826 % 10 M €

Company contact information

Hansoh Pharmaceutical Group Co., Ltd.

287 Xiangke Road Pudong New District

201210, Shanghai

+

http://www.hspharm.com
address Hansoh Pharmaceutical Group Company Limited(3KY)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Ratings for Hansoh Pharmaceutical Group Company Limited

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
15.67 CNY
Average target price
18.11 CNY
Spread / Average Target
+15.55%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+54.61% 811B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+43.76% 640B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.33% 353B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.62% 333B
ABBVIE INC. Stock AbbVie Inc.
+10.44% 302B
ASTRAZENECA PLC Stock AstraZeneca PLC
+18.09% 246B
ROCHE HOLDING AG Stock Roche Holding AG
+2.66% 225B
NOVARTIS AG Stock Novartis AG
+12.88% 218B
AMGEN INC. Stock Amgen Inc.
+8.61% 168B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 3692 Stock
  4. 3KY Stock
  5. Company Hansoh Pharmaceutical Group Company Limited